Galmed Pharmaceuticals Stock Performance

GLMD Stock  USD 0.79  0.03  3.66%   
The company retains a Market Volatility (i.e., Beta) of 1.33, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Galmed Pharmaceuticals will likely underperform. At this point, Galmed Pharmaceuticals has a negative expected return of -0.75%. Please make sure to check out Galmed Pharmaceuticals' treynor ratio, accumulation distribution, period momentum indicator, as well as the relationship between the potential upside and day median price , to decide if Galmed Pharmaceuticals performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Galmed Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's primary indicators remain rather sound which may send shares a bit higher in February 2026. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders. ...more
Last Split Factor
1:12
Last Split Date
2024-08-30
1
Galmed Pharmaceuticals Reschedules Annual General Meeting Due to Lack of Quorum - TipRanks
10/28/2025
2
Galmed Announces Top-line Results in Oncology MoA Studies A 3-drug combination of Aramchol, Stivarga and Metformin Significantly Enhanced GI Tumor Cells, Killin...
11/17/2025
3
Liver Fibrosis Research Report 2025-2035 Market Driven by Innovation from Akero, Sagimet, Inventiva, Novo Nordisk, Viking, Boston Pharma, Aligos, Boehringer Ing...
11/18/2025
4
Galmed Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update
11/26/2025
5
Galmed Announces Grant of New Use Patents for the combination of Aramchol and Madrigal Pharmaceuticals Rezdiffra for MASH
12/04/2025
6
Is Galmed Pharmaceuticals Ltd. stock a safe buy pre earnings - Market Trend Review Weekly Top Gainers Trade List - DonanmHaber
12/19/2025
7
How volatile is Galmed Pharmaceuticals Ltd stock - Trade Analysis Summary Scalable Portfolio Growth Methods - baoquankhu1.vn
01/15/2026
Begin Period Cash FlowM
Total Cashflows From Investing Activities-1.1 M

Galmed Pharmaceuticals Relative Risk vs. Return Landscape

If you would invest  135.00  in Galmed Pharmaceuticals on October 29, 2025 and sell it today you would lose (56.00) from holding Galmed Pharmaceuticals or give up 41.48% of portfolio value over 90 days. Galmed Pharmaceuticals is currently does not generate positive expected returns and assumes 5.2403% risk (volatility on return distribution) over the 90 days horizon. In different words, 47% of stocks are less volatile than Galmed, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Galmed Pharmaceuticals is expected to under-perform the market. In addition to that, the company is 7.02 times more volatile than its market benchmark. It trades about -0.14 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.09 per unit of volatility.

Galmed Pharmaceuticals Target Price Odds to finish over Current Price

The tendency of Galmed Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 0.79 90 days 0.79 
about 85.26
Based on a normal probability distribution, the odds of Galmed Pharmaceuticals to move above the current price in 90 days from now is about 85.26 (This Galmed Pharmaceuticals probability density function shows the probability of Galmed Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.33 . This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Galmed Pharmaceuticals will likely underperform. Additionally Galmed Pharmaceuticals has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Galmed Pharmaceuticals Price Density   
       Price  

Predictive Modules for Galmed Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Galmed Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.040.796.07
Details
Intrinsic
Valuation
LowRealHigh
0.040.766.04
Details
Naive
Forecast
LowNextHigh
0.020.916.19
Details
1 Analysts
Consensus
LowTargetHigh
10.9212.0013.32
Details

Galmed Pharmaceuticals Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Galmed Pharmaceuticals is not an exception. The market had few large corrections towards the Galmed Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Galmed Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Galmed Pharmaceuticals within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.86
β
Beta against Dow Jones1.33
σ
Overall volatility
0.21
Ir
Information ratio -0.16

Galmed Pharmaceuticals Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Galmed Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Galmed Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Galmed Pharmaceuticals generated a negative expected return over the last 90 days
Galmed Pharmaceuticals has high historical volatility and very poor performance
Galmed Pharmaceuticals has some characteristics of a very speculative penny stock
Galmed Pharmaceuticals has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (7.52 M) with profit before overhead, payroll, taxes, and interest of 0.
Galmed Pharmaceuticals currently holds about 22.4 M in cash with (5.88 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.89, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Latest headline from news.google.com: How volatile is Galmed Pharmaceuticals Ltd stock - Trade Analysis Summary Scalable Portfolio Growth Methods - baoquankhu1.vn

Galmed Pharmaceuticals Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Galmed Stock often depends not only on the future outlook of the current and potential Galmed Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Galmed Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding930.8 K
Cash And Short Term Investments15.3 M

Galmed Pharmaceuticals Fundamentals Growth

Galmed Stock prices reflect investors' perceptions of the future prospects and financial health of Galmed Pharmaceuticals, and Galmed Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Galmed Stock performance.

About Galmed Pharmaceuticals Performance

By analyzing Galmed Pharmaceuticals' fundamental ratios, stakeholders can gain valuable insights into Galmed Pharmaceuticals' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Galmed Pharmaceuticals has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Galmed Pharmaceuticals has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand1.1 K951
Return On Tangible Assets(0.37)(0.38)
Return On Capital Employed(0.35)(0.36)
Return On Assets(0.37)(0.38)
Return On Equity(0.53)(0.50)

Things to note about Galmed Pharmaceuticals performance evaluation

Checking the ongoing alerts about Galmed Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Galmed Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Galmed Pharmaceuticals generated a negative expected return over the last 90 days
Galmed Pharmaceuticals has high historical volatility and very poor performance
Galmed Pharmaceuticals has some characteristics of a very speculative penny stock
Galmed Pharmaceuticals has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (7.52 M) with profit before overhead, payroll, taxes, and interest of 0.
Galmed Pharmaceuticals currently holds about 22.4 M in cash with (5.88 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.89, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Latest headline from news.google.com: How volatile is Galmed Pharmaceuticals Ltd stock - Trade Analysis Summary Scalable Portfolio Growth Methods - baoquankhu1.vn
Evaluating Galmed Pharmaceuticals' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Galmed Pharmaceuticals' stock performance include:
  • Analyzing Galmed Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Galmed Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
  • Examining Galmed Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Galmed Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Galmed Pharmaceuticals' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Galmed Pharmaceuticals' stock. These opinions can provide insight into Galmed Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Galmed Pharmaceuticals' stock performance is not an exact science, and many factors can impact Galmed Pharmaceuticals' stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Galmed Stock analysis

When running Galmed Pharmaceuticals' price analysis, check to measure Galmed Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Galmed Pharmaceuticals is operating at the current time. Most of Galmed Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Galmed Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Galmed Pharmaceuticals' price. Additionally, you may evaluate how the addition of Galmed Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges